Hauptkonkurrenten
Dividendenrendite (N) Dividendenrendite (N+1) KGV (N) Price to Book (N) EV / Sales (N) Marktkap. / EBITDA (N) Marktkap. / EBIT (N) Kap.($)
- - - - - - - 319.235
0,81 %0,91 %35.6x5.02x6.74x23.27x28.13x 48,56 Mrd.
1,32 %1,41 %18.17x1.78x2.06x9.66x12.57x 35,65 Mrd.
0,86 %0,97 %27.48x3.07x3.4x17.39x22.06x 11,98 Mrd.
0,58 %0,59 %27.35x3.76x4.03x16.4x22.46x 11,95 Mrd.
3,39 %3,74 %19.62x3.35x3.43x12.34x14.65x 9,29 Mrd.
5,14 %5,5 %8.43x1.46x1.98x5.19x6.29x 6,95 Mrd.
3,34 %3,3 %15.54x1.25x1.99x6.68x9.14x 6,79 Mrd.
0,23 %0,23 %34.71x6.14x3.96x16.84x18.6x 6,7 Mrd.
0,96 %1,16 %41.18x9.47x7.89x29.26x32.67x 4,48 Mrd.
2,93 %3,83 %17.37x2.78x2.77x12.95x12.55x 4,3 Mrd.
1,27 %1,72 %15.44x0.74x2.1x9.06x11.5x 4,06 Mrd.
3,05 %3,39 %19.74x5.29x6.16x17.51x18.95x 2,74 Mrd.
2,9 %2,98 %13.64x2.75x3.17x11.82x13.06x 2,71 Mrd.
Durchschnitt 2,06 % 2,29 % 22,64x 3,60x 3,82x 14,49x 17,13x 11,15 Mrd.
Gewichteter Durchschnitt nach Marktkapitalisierung 1,5 % 1,64 % 25,77x 3,58x 4,20x 15,95x 19,52x
Generische Pharmazeutika